This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Pharma Clinical Trial Services: World Market 2013-2023

What prospects for leading regions and countries?

Developments worldwide will influence the market from 2013, especially improving clinical research in developing countries. There exist many opportunities for pharmaceutical companies and contract research providers. See outlooks for clinical testing.

You get individual forecasts to 2023 for 12 national markets and two regional groups, finding overall revenues:• US• Japan• Western Europe• Central and Eastern Europe (CEE)• Germany, France, UK, Italy and Spain (EU5)• Brazil, Russia, India and China (BRIC nations) and South Korea.

Discover progress and outlooks. You assess the industry's future - hear about developments and find their significance. Our work explains, exploring many issues.

What affects clinical trial services from 2013?

Our report discusses issues and events affecting that industry and market from 2013:

• Future of outsourced phase I, II and III trials and post-marketing studies

• Demand from pharmaceutical and biopharma companies

• Regulatory policy

• Challenges in developed and developing countries

• Adaptive trial designs and focus on late-stage R&D pipeline candidates

• Patient recruitment and retention.

Also, we discuss these aspects of the field:• Social media as tools for engaging patients• Technological progress for more-efficient trials• Sharing of risk between the pharma industry and CROs• CRO consolidation, specialisation and globalisation• Studies on orphan diseases• Biomarkers in drug development.

See what the future holds. You investigate technological, economic and political matters, finding emphasis on companies, competition and business outlooks.

Leading companies and 2015 market value

We predict that the overall world market for clinical trial services will reach $30.6bn in 2015, and expand further to 2023. That outsourcing segment holds great potential for investment, development and revenue growth from 2013. You see how it will progress.

We review 15 leading companies, including these:• Quintiles• Covance• PPD• Parexel International• ICON• INC Research• inVentiv Health.

2 of 13

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,797.42 -245.48 -1.44%
S&P 500 1,948.94 -23.35 -1.18%
NASDAQ 4,425.1030 -68.2870 -1.52%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs